EdgarLookup

Tenaya Therapeutics, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
COLUMN GROUP III, LP Purchase 9,615,384 $2.60 $24,999,998 9,615,384 Nov 21, 2022
Srivastava Deepak Purchase 230,769 $2.60 $599,999 372,435 Nov 21, 2022
Casdin Capital, LLC Purchase 2,492,042 $2.60 $6,479,309 6,078,860 Nov 17, 2022
Hoey Timothy Chief Scientific Officer Sale 1,353 $10.13 $13,706 198,646 Apr 26, 2022
Kang JeenJoo C 12,500 25,000 Aug 3, 2021
GOEDDEL DAVID V C 4,389,282 4,414,720 Aug 3, 2021
Casdin Eli C 2,374,849 2,374,849 Aug 3, 2021
Casdin Private Growth Equity Fund, L.P. C 361,969 361,969 Aug 3, 2021
COLUMN GROUP III, LP C 4,956,842 4,985,570 Aug 3, 2021